CD4 and arthritic joint disease: It remains to be established whether the long-term protection from arthritis afforded following anti-CD4 treatment, even after a new curdlan challenge at a later time, can be explained by the development of regulatory mechanisms that have been described in other animal models of anti-CD4 induced immune tolerance [28], [35].